Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 3 | 4 | 5 | 6 |
| Accounts receivable | -140 | 15 | -25 | -63 | -23 |
| Other Working Capital | -405 | 192 | 227 | -138 | 270 |
| Other Operating Activity | -232 | -300 | -345 | -426 | -479 |
| Operating Cash Flow | $-775 | $-91 | $-139 | $-622 | $-226 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | 0 | 0 | 0 | 0 | 13 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 853 | 126 | 14 | 725 | 154 |
| Financing Cash Flow | $853 | $126 | $14 | $725 | $154 |
| Beginning Cash Position | 47 | 13 | 137 | 34 | 113 |
| End Cash Position | 124 | 47 | 13 | 137 | 36 |
| Net Cash Flow | $78 | $35 | $-125 | $103 | $-59 |
| Free Cash Flow | |||||
| Operating Cash Flow | -775 | -91 | -139 | -622 | -226 |
| Free Cash Flow | -775 | -91 | -139 | -622 | -226 |